WEST CHESTER, Pa., July 24, 2024 /PRNewswire/ — Centinel Spine®, LLC (“the Company”), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of record revenue in the second quarter of 2024—outperforming Q1 2024, its previous record quarter.
Centinel Spine remains the fastest growing company in the spine industry* and is dedicated exclusively to total disc replacement, one of the fastest growing segments in orthopedic implants.
The Company remains well-positioned from a profitability perspective, achieving a record EBITDA quarter in Q2 2024** and its fifth consecutive adjusted EBITDA positive quarter.
Second Quarter 2024 Highlights
Highlights on the New Match-the-Disc™ prodisc C Vivo & prodisc C SK Cervical System
Centinel Spine CEO Steve Murray adds, “The second quarter represents another record performance for Centinel Spine and these results demonstrate the continued strength behind our prodisc cervical and lumbar business in the rapidly expanding Total Disc Replacement market, worldwide. The prodisc portfolio leads the Total Disc Replacement market in growth and has a long history of reliability and long-term performance. The new prodisc C Vivo and prodisc C SK cervical system continues to excel, as exhibited by a rapidly expanding user base, record new users for the quarter, and strong repeat usage performance.”
* Based on publicly available information.
** Q2 2024 adjusted EBITDA is based on unaudited financials.
About Centinel Spine, LLC
Centinel Spine®, LLC is the leading global medical device company exclusively focused on addressing cervical and lumbar spinal disease with prodisc®, the most complete total disc replacement (TDR) technology platform in the world.
The Company’s prodisc technology is the most studied and clinically-proven TDR system across the globe, validated by over 540 published papers and more than 250,000 implantations. Centinel Spine’s prodisc is the only TDR technology with multiple motion-preserving anatomic solutions, allowing the surgeon to Match-the-Disc™ to each patient’s anatomy for both cervical and lumbar total disc replacement.
For more information, please visit the company’s website at www.CentinelSpine.com or contact:
Varun Gandhi
Chief Financial Officer
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: v.gandhi@centinelspine.com
SOURCE Centinel Spine, LLC
Evosep Eno The new Evosep Eno from Evosep will set the stage for next generation…
Framework Sets an Industry Benchmark for Client Trust and Ethical AI Use to Ensure Patient…
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in…
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60%…
New name, new brand better reflects the company’s position as a global, commercial-scale biomanufacturer Liberation…
Collaboration includes use of PathAI’s AISight®¹ digital pathology image management system at Northwestern Medicine and…